Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with Thiostrepton
暂无分享,去创建一个
W. Lowther | N. Heintz | K. Nelson | T. Messier | A. Saaman | B. Cunniff | S. Beuschel | Uma Gandhi | T. Smalley | Stephanie Milczarek | Stacie L. Beuschel
[1] H. Sikes,et al. Kinetic modeling of H2O2 dynamics in the mitochondria of HeLa cells , 2020, PLoS Comput. Biol..
[2] T. Dick,et al. Real-time monitoring of peroxiredoxin oligomerization dynamics in living cells , 2020, Proceedings of the National Academy of Sciences.
[3] Min Suk Shim,et al. Mitochondria-targeted drug delivery in cancers. , 2020, Biochimica et biophysica acta. Molecular basis of disease.
[4] C. Furdui,et al. Introduction to approaches and tools for the evaluation of protein cysteine oxidation. , 2020, Essays in biochemistry.
[5] Joshua A. Bittker,et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling , 2020, Nature Cancer.
[6] Dong-Seok Lee,et al. Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression , 2019, International journal of molecular sciences.
[7] W. Lowther,et al. Aromatic Residues at the Dimer-Dimer Interface in the Peroxiredoxin Tsa1 Facilitate Decamer Formation and Biological Function. , 2019, Chemical research in toxicology.
[8] Joshua E. Lewis,et al. Peroxiredoxins in Cancer and Response to Radiation Therapies , 2019, Antioxidants.
[9] V. Scalcon,et al. Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors , 2018, Free radical biology & medicine.
[10] D. S. St. Clair,et al. Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer. , 2018, Antioxidants & redox signaling.
[11] W. Lowther,et al. Novel hyperoxidation resistance motifs in 2-Cys peroxiredoxins , 2018, The Journal of Biological Chemistry.
[12] J. Gerrard,et al. Quaternary structure influences the peroxidase activity of peroxiredoxin 3. , 2018, Biochemical and biophysical research communications.
[13] D. Barber,et al. Cancer cell behaviors mediated by dysregulated pH dynamics at a glance , 2017, Journal of Cell Science.
[14] W. Lowther,et al. Kinetic analysis of structural influences on the susceptibility of peroxiredoxins 2 and 3 to hyperoxidation. , 2016, The Biochemical journal.
[15] Edward T Chouchani,et al. Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma , 2015, PloS one.
[16] M. Murakami,et al. How pH Modulates the Dimer-Decamer Interconversion of 2-Cys Peroxiredoxins from the Prx1 Subfamily* , 2015, The Journal of Biological Chemistry.
[17] J. Reisz,et al. Thiol‐blocking electrophiles interfere with labeling and detection of protein sulfenic acids , 2013, The FEBS journal.
[18] T. Mak,et al. Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.
[19] W. Lowther,et al. Molecular Basis for the Resistance of Human Mitochondrial 2-Cys Peroxiredoxin 3 to Hyperoxidation* , 2013, The Journal of Biological Chemistry.
[20] N. Heintz,et al. Mitochondrial‐targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells , 2013, Journal of cellular physiology.
[21] H. Pass,et al. Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells , 2012, PloS one.
[22] G. Wondrak,et al. Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. , 2012, Biochemical pharmacology.
[23] L. Poole,et al. Kinetic and thermodynamic features reveal that Escherichia coli BCP is an unusually versatile peroxiredoxin. , 2011, Biochemistry.
[24] P Andrew Karplus,et al. Structural evidence that peroxiredoxin catalytic power is based on transition-state stabilization. , 2010, Journal of molecular biology.
[25] W. Lowther,et al. Protein Engineering of the Quaternary Sulfiredoxin·Peroxiredoxin Enzyme·Substrate Complex Reveals the Molecular Basis for Cysteine Sulfinic Acid Phosphorylation* , 2009, The Journal of Biological Chemistry.
[26] N. Chandel,et al. Reactive oxygen species-dependent signaling regulates cancer , 2009, Cellular and Molecular Life Sciences.
[27] J. Pullar,et al. Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxins. , 2009, The Biochemical journal.
[28] P. Karplus,et al. Cysteine pK(a) values for the bacterial peroxiredoxin AhpC. , 2008, Biochemistry.
[29] M. Murphy,et al. Targeting lipophilic cations to mitochondria. , 2008, Biochimica et biophysica acta.
[30] C. Winterbourn,et al. Reconciling the chemistry and biology of reactive oxygen species. , 2008, Nature chemical biology.
[31] N. Doudican,et al. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism , 2008, Cancer Chemotherapy and Pharmacology.
[32] W. Lowther,et al. Structure of the sulphiredoxin–peroxiredoxin complex reveals an essential repair embrace , 2008, Nature.
[33] N. Brot,et al. Free methionine-(R)-sulfoxide reductase from Escherichia coli reveals a new GAF domain function , 2007, Proceedings of the National Academy of Sciences.
[34] N. Isaacs,et al. Bovine mitochondrial peroxiredoxin III forms a two-ring catenane. , 2005, Structure.
[35] P. Karplus,et al. Analysis of the link between enzymatic activity and oligomeric state in AhpC, a bacterial peroxiredoxin. , 2005, Biochemistry.
[36] J. Jacquot,et al. Effect of pH on the oxidation-reduction properties of thioredoxins. , 2003, Biochemistry.
[37] P. Karplus,et al. Peroxiredoxin Evolution and the Regulation of Hydrogen Peroxide Signaling , 2003, Science.
[38] Y. Soini,et al. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma , 2002, The Journal of pathology.
[39] Robin A. J. Smith,et al. Drug delivery to mitochondria: the key to mitochondrial medicine. , 2000, Advanced drug delivery reviews.
[40] Joan C. Han,et al. A procedure for quantitative determination of tris(2-carboxyethyl)phosphine, an odorless reducing agent more stable and effective than dithiothreitol. , 1994, Analytical biochemistry.
[41] W. de Souza,et al. The mitochondrion of Trypanosoma cruzi is a target of crystal violet toxicity. , 1989, Molecular and biochemical parasitology.
[42] C. Winterbourn,et al. Hyperoxidation of peroxiredoxins 2 and 3: Rate constants for the reactions of the sulfenic acid of the peroxidatic cysteine , 2013 .